Axsome Therapeutics (AXSM) PT Raised to $143 at RBC Following Symbravo's Approval
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| (NASDAQ: AXSM) | Delayed: 135.28 -4.33 (3.1%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $139.61 | 52 Week High | $15.74 | |||
| Open | $140.56 | 52 Week Low | $5.37 | |||
| Day High | $140.56 | P/E | N/A | |||
| Day Low | $135.28 | EPS | $0.00 | |||
| Volume | 72,320 | |||||
